Management of Long COVID and Chronic Fatigue Syndrome
Introduction to Treatment Options
- Nicotine has demonstrated anti-inflammatory properties in animal models through activation of the cholinergic anti-inflammatory pathway, decreased lung vascular permeability, and reduced leukocyte infiltration and proinflammatory cytokine concentrations, according to the Lancet Respiratory Medicine 1
Recommended Treatment Options
- The Nature Reviews Microbiology guidelines recommend coenzyme Q10 and D-ribose supplements, low-dose naltrexone for pain, fatigue, and neurological symptoms, and low-dose aripiprazole for fatigue, unrefreshing sleep, and brain fog for treating fatigue in patients with long COVID or CFS 2
- The Nature Reviews Microbiology guidelines suggest pacing (activity management) for postexertional malaise, and advise against exercise, cognitive behavioral therapy, and graded exercise therapy which are contraindicated 2
- The Nature Reviews Microbiology guidelines recommend β-blockers, pyridostigmine, fludrocortisone, midodrine, and non-pharmacological approaches such as increased salt and fluid intake, and compression stockings for autonomic dysfunction in patients with long COVID or CFS 2
Exercise and Therapy
- Exercise can worsen symptoms in 75% of patients with long COVID who have ME/CFS or postexertional malaise, according to the Nature Reviews Microbiology guidelines 2
- Graded exercise therapy and cognitive behavioral therapy remain controversial for ME/CFS and should be further investigated before being recommended for long COVID, as stated by Clinical Microbiology and Infection 3
Investigational Treatments
- Paxlovid (antiviral) has shown potential in case reports and deserves further study for treating long COVID, according to the Nature Reviews Microbiology guidelines 2
- Anticoagulants have shown promise in addressing abnormal clotting in long COVID, as recommended by the Nature Reviews Microbiology guidelines 2
- Nicotine or nicotine replacement therapy is not recommended for the treatment of long COVID due to its adverse cardiopulmonary effects and addictive potential, as stated by the medical community 1, 4
- For patients who smoke and have COVID-19 or long COVID, smoking cessation is strongly encouraged, and standard nicotine replacement therapy may be considered only as part of a smoking cessation strategy, not as COVID-19 treatment 4, 1